GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet?

Tytuł:: GLP-1 receptor agonists in type 1 diabetes: a MAG1C bullet?
Autorzy:: Nauck MA; Diabetes Division, Katholisches Klinikum Bochum, St Josef Hospital, Ruhr-University Bochum, D-44791 Bochum, Germany. Electronic address: .
Meier JJ; Diabetes Division, Katholisches Klinikum Bochum, St Josef Hospital, Ruhr-University Bochum, D-44791 Bochum, Germany.
Źródło:: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2020 Apr; Vol. 8 (4), pp. 262-264. Date of Electronic Publication: 2020 Mar 02.
Typ publikacji:: Journal Article; Comment
Język:: English
Imprint Name(s):: Original Publication: London : The Lancet, Diabetes & Endocrinology, [2013]-
MeSH Terms:: Diabetes Mellitus, Type 1*
Exenatide*
Blood Glucose ; Double-Blind Method ; Glucagon-Like Peptide-1 Receptor ; Humans ; Hypoglycemic Agents
Substance Nomenclature:: 0 (Blood Glucose)
0 (Glucagon-Like Peptide-1 Receptor)
0 (Hypoglycemic Agents)
9P1872D4OL (Exenatide)
Entry Date(s):: Date Created: 20200306 Date Completed: 20200709 Latest Revision: 20200709
Update Code:: 20240105
DOI:: 10.1016/S2213-8587(20)30043-7
PMID:: 32135134
: Czasopismo naukowe

Comment on: Lancet Diabetes Endocrinol. 2020 Apr;8(4):313-324. (PMID: 32135138)

Informacja